ExamWorks Group, which offers independent reviews used to assess insurance claims to its medical provider clients, announced terms for its IPO on Wednesday. The Atlanta, GA-based company plans to raise $175 million by offering 10.3 million shares at a price range of $16-$18. At the mid-point of the proposed range, ExamWorks Group will command a market value of $568 million. ExamWorks Group, which was founded in 2007 and booked $91 million in sales for the 12 months ended June 30, plans to list on the NYSE under the symbol EXAM. Goldman, Sachs & Co., Credit Suisse and Barclays Capital are the lead underwriters on the deal, for which timing was not disclosed.
